1.
Landers J, Walker C, Skaddy T. Telmisartan for Apolipoprotein E ε4 Carriers as a Candidate Precision Medicine Strategy in Alzheimer’s Disease. J Neurol Res [Internet]. 2026 Jan. 1 [cited 2026 Aug. 5];16(3):150-7. Available from: https://jnr.elmerpub.com/index.php/jnr/article/view/1122